Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of bovine calf intestinal alkaline phosphatase in moderate to severe ulcerative colitis
2006-000197-69Phase 2Completed
- Sponsor
- AM-Pharma
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bovine calf intestinal alkaline phosphatase in autoimmune colitis, sponsored by AM-Pharma. Primary endpoint: Safety and tolerability of BIAP. Started Mar 2006; status: completed.
02
Drugs
bovine calf intestinal alkaline phosphatase
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2006-000197-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000197-69.